FDA approval summary: sunitinib for the treatment of progressive well-differentiated locally advanced or metastatic pancreatic neuroendocrine tumors (Q36182844)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | FDA approval summary: sunitinib for the treatment of progressive well-differentiated locally advanced or metastatic pancreatic neuroendocrine tumors |
scientific article |
Statements
1 reference
FDA approval summary: sunitinib for the treatment of progressive well-differentiated locally advanced or metastatic pancreatic neuroendocrine tumors (English)
1 reference
Gideon M Blumenthal
1 reference
Patricia Cortazar
1 reference
Jenny J Zhang
1 reference
Shenghui Tang
1 reference
Rajeshwari Sridhara
1 reference
Anthony Murgo
1 reference
Robert Justice
1 reference
Richard Pazdur
1 reference
26 July 2012
1 reference
1 reference
1108-1113
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference